ICS OPPORTUNITIES II LLC

Track record of ICS OPPORTUNITIES II LLC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of ICS OPPORTUNITIES II LLC

Co-insiders of ICS OPPORTUNITIES II LLC

• Angermayer ChristianSensei Biotherapeutics, Inc.
• Apeiron Investment Group Ltd.Sensei Biotherapeutics, Inc.
• Broder SamuelSensei Biotherapeutics, Inc.
• Cambrian BioPharma IncSensei Biotherapeutics, Inc.
• Celebi JohnSensei Biotherapeutics, Inc.
• Colgan ErinSensei Biotherapeutics, Inc.
• Craver JosiahSensei Biotherapeutics, Inc.
• DONENBERG PHILIP BSensei Biotherapeutics, Inc.
• ENGLANDER ISRAEL ASensei Biotherapeutics, Inc.
• English JessieSensei Biotherapeutics, Inc.
• Fjaellskog Marie-LouiseSensei Biotherapeutics, Inc.
• Gaiero David GSensei Biotherapeutics, Inc.
• Gallagher Patrick StephenSensei Biotherapeutics, Inc.
• Gerry ChristopherSensei Biotherapeutics, Inc.
• Hahn Stephen M.Sensei Biotherapeutics, Inc.
• Hoey AnupamaSensei Biotherapeutics, Inc.
• Holmen BobSensei Biotherapeutics, Inc.
• H&S INVESTMENTS I LPSensei Biotherapeutics, Inc.
• H&S VENTURES LLCSensei Biotherapeutics, Inc.
• Humer KristianSensei Biotherapeutics, Inc.
• Krebs StephanieSensei Biotherapeutics, Inc.
• MILLENNIUM INTERNATIONAL MANAGEMENT GP LLCSensei Biotherapeutics, Inc.
• MILLENNIUM MANAGEMENT, L.L.C.Sensei Biotherapeutics, Inc.
• Parikh Anand KiranSensei Biotherapeutics, Inc.
• Peyer JamesSensei Biotherapeutics, Inc.
• Pierce Robert HamiltonSensei Biotherapeutics, Inc.
• Presight Co-Invest Management, L.L.C.Sensei Biotherapeutics, Inc.
• Presight Sensei Co-Invest Fund, L.P.Sensei Biotherapeutics, Inc.
• Ramasastry SairaSensei Biotherapeutics, Inc.
• RICKS THOMAS GSensei Biotherapeutics, Inc.
• RINGO WILLIAM RSensei Biotherapeutics, Inc.
• SAMUELI HENRYSensei Biotherapeutics, Inc.
• SAMUELI SUSANSensei Biotherapeutics, Inc.
• SCHULMAN MICHAELSensei Biotherapeutics, Inc.
• STEPHENSON BRIAN CSensei Biotherapeutics, Inc.
• van der Horst EdwardSensei Biotherapeutics, Inc.
• Vojta DeneenSensei Biotherapeutics, Inc.